Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epiduo Regimen in Mild to Moderate Acne
NCT01951417Phase 4Completed
- Sponsor
- Galderma
- Start
- Oct 2013
- Primary completion
- Mar 2014
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adapalene + benzoyl peroxide in acne vulgaris, sponsored by Galderma. Primary endpoint: Total Lesion Count at 8 weeks. Started Oct 2013; status: completed.
02
Drugs
adapalene + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01951417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01951417.